Home

Παραλία παρέμβαση Γλωσσολογία kappa opioid receptor non small lung cancer λάμπα Πάντα Κομόραμα

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

Effect of κ-opioid receptor agonist on the growth of non-small cell lung  cancer (NSCLC) cells | British Journal of Cancer
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer

Biomedicines | Free Full-Text | δ-Opioid Receptor as a Molecular  Target for Increasing Cardiac Resistance to Reperfusion in Drug Development
Biomedicines | Free Full-Text | δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development

The Role of Opioids and Their Receptors in Urological Malignancy: A Review
The Role of Opioids and Their Receptors in Urological Malignancy: A Review

Frontiers | Nociceptin Receptor Is Overexpressed in Non-small Cell Lung  Cancer and Predicts Poor Prognosis
Frontiers | Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic  Targets: Recent Progress and Future Perspective
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective

Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Scientists Take a Big Step toward Building a Better Opioid | Newsroom

Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... |  Download Scientific Diagram
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram

Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes  the immune escape of non-small cell lung cancer | Cancer Biology & Medicine
Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer | Cancer Biology & Medicine

Opioid receptors beyond pain control: The role in cancer pathology and the  debated importance of their pharmacological modulation - ScienceDirect
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation - ScienceDirect

IJMS | Free Full-Text | The Downregulation of Opioid Receptors and  Neuropathic Pain
IJMS | Free Full-Text | The Downregulation of Opioid Receptors and Neuropathic Pain

Frontiers | Heteromerization Modulates mu Opioid Receptor Functional  Properties in vivo
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo

Opioid Receptor | kappa, mu Opioid Receptor
Opioid Receptor | kappa, mu Opioid Receptor

Frontiers | Opioid Receptors in Immune and Glial Cells—Implications for  Pain Control
Frontiers | Opioid Receptors in Immune and Glial Cells—Implications for Pain Control

Effect of κ-opioid receptor agonist on the growth of non-small cell lung  cancer (NSCLC) cells | British Journal of Cancer
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer

Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid  Receptor System in the Actions of Alcohol
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol

Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal  Chemistry
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry

Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic  Tethered Compounds May Improve Specificity, Lower Dosage and Enhance  Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

The mu-opioid receptor is a molecular marker for poor prognosis in  hepatocellular carcinoma and represents a potential therapeutic target -  British Journal of Anaesthesia
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target - British Journal of Anaesthesia

Non-Small Cell Lung Cancer (NSCLC) Workup: Approach Considerations,  Laboratory Studies, Chest Radiography
Non-Small Cell Lung Cancer (NSCLC) Workup: Approach Considerations, Laboratory Studies, Chest Radiography

Molecular mechanism of biased signaling at the kappa opioid receptor |  Nature Communications
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)

RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC  proliferation, invasion and metastasis via the PDK1-AKT signaling pathway |  Cell Communication and Signaling | Full Text
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text

Elucidating the active δ-opioid receptor crystal structure with peptide and  small-molecule agonists | Science Advances
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances

Effect of κ-opioid receptor agonist on the growth of non-small cell lung  cancer (NSCLC) cells | British Journal of Cancer
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer

Untangling the complexity of opioid receptor function |  Neuropsychopharmacology
Untangling the complexity of opioid receptor function | Neuropsychopharmacology